Dataset Information

Drugs Being Eliminated via the Same Pathway Will Not Always Require Similar Pediatric Dose Adjustments.

ABSTRACT: For scaling drug plasma clearance (CLp) from adults to children, extrapolations of population pharmacokinetic (PopPK) covariate models between drugs sharing an elimination pathway have enabled accelerated development of pediatric models and dosing recommendations. This study aims at identifying conditions for which this approach consistently leads to accurate pathway specific CLp scaling from adults to children for drugs undergoing hepatic metabolism. A physiologically based pharmacokinetic (PBPK) simulation workflow utilizing mechanistic equations defining hepatic metabolism was developed. We found that drugs eliminated via the same pathway require similar pediatric dose adjustments only in specific cases, depending on drugs extraction ratio, unbound fraction, type of binding plasma protein, and the fraction metabolized by the isoenzyme pathway for which CLp is scaled. Overall, between-drug extrapolation of pediatric covariate functions for CLp is mostly applicable to low and intermediate extraction ratio drugs eliminated by one isoenzyme and binding to human serum albumin in children older than 1 month.

SUBMITTER: Calvier EAM

PROVIDER: S-EPMC5869561 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Drugs Being Eliminated via the Same Pathway Will Not Always Require Similar Pediatric Dose Adjustments.

Calvier Elisa A M EAM Krekels Elke H J EHJ Yu Huixin H Välitalo Pyry A J PAJ Johnson Trevor N TN Rostami-Hodjegan Amin A Tibboel Dick D van der Graaf Piet H PH Danhof Meindert M Knibbe Catherijne A J CAJ

CPT: pharmacometrics & systems pharmacology 20180205 3

For scaling drug plasma clearance (CLp) from adults to children, extrapolations of population pharmacokinetic (PopPK) covariate models between drugs sharing an elimination pathway have enabled accelerated development of pediatric models and dosing recommendations. This study aims at identifying conditions for which this approach consistently leads to accurate pathway specific CLp scaling from adults to children for drugs undergoing hepatic metabolism. A physiologically based pharmacokinetic (PBP ...[more]

PMID: 29399979

Similar Datasets

Project description:BackgroundIn general, hypothyroidism can be adequately treated with a consistent daily dose of levothyroxine. However, the need for levothyroxine dose adjustments is frequent in clinical practice. The extent to which levothyroxine dose adjustments increase the utilization of healthcare resources has not previously been described in the clinical literature.ObjectiveThe primary objective of our study was to measure the effect of levothyroxine dose adjustments in terms of their utilization of healthcare resources including direct and indirect costs. A secondary goal was to identify any differences in patient characteristics that may be responsible for levothyroxine dose adjustments.MethodsA retrospective medical chart review was conducted among patients of selected healthcare providers in the USA. Patients who were recently started on levothyroxine therapy (<6 months) were excluded to avoid situations that were more likely attributable to treatment initiation than inadequate therapeutic effect. Trained nurses extracted data from patient charts and electronic medical record systems for review. We analyzed the cost of resources consumed by the frequency of levothyroxine dose changes over 24 months: 0 dose changes (no dose adjustment group); one dose change, two dose changes, three or more dose changes (≥1 dose adjustment group).ResultsThe study included 454 patients. Overall estimated resource utilization was higher per patient in the ≥1 dose adjustment group (US$5824) vs. the no dose adjustment group (US$3166) during the 24-month study period. When direct and indirect costs were combined, overall costs of care were greatest in patients requiring three or more dose adjustments (US$8220/patient). Patients in this cohort incurred 2.5-fold greater total costs compared with patients requiring no dose adjustments (US$8220 vs. US$3166). Among the 58 patients in the group requiring three or more dose adjustments, mean direct medical costs were significantly higher than in the patients requiring no dose adjustments (US$6387 vs. US$2182). Patients with at least one dose adjustment experienced a 40.3% increase in lost productivity vs. patients who had no dose adjustments (US$1381 vs. US$984). Loss of productivity was highest among patients with three or more levothyroxine dose adjustments. Among this cohort, there was an 86.4% increase in lost productivity vs. patients who had no levothyroxine dose adjustments (US$1833 vs. US$984).ConclusionsPatients experiencing multiple levothyroxine dose adjustments were shown to consume more healthcare resources, resulting in higher costs than those who required no dose adjustments. Each care episode contributed to lost time and wages with total estimated lost productivity escalating with increasing levothyroxine dose adjustments over a 24-month period.

Project description:The grapevine (Vitis vinifera L.) is managed to balance the ratio of leaf area (source) to fruit mass (sink). Over cropping in the grapevine may reveal itself as spontaneous fruit abortion, delayed ripening, or as alternate bearing. The aim of this work was to study the same season and carry-over effects of manipulating source to sink ratios on grapevine phenology, leaf gas exchange, yield components, berry soluble solids accumulation, and reserve carbohydrate and soluble sugar concentration in roots. Cabernet Sauvignon grapevines were subjected to defoliation (33, 66, and 100% of the leaves retained) and fruit removal treatments (33, 66, and 100% of clusters retained) arranged in a factorial design. Results from two seasons of source-sink manipulations were substantially different. In both seasons defoliation treatments affected season-long net carbon assimilation (A N ) and stomatal conductance (g s ) where the less leaves were retained, the greater the A N and g s , and fruit removal had no impact on leaf gas exchange. In the first season, leaf area to fruit mass was hardly related to berry soluble solids and in the second season they were strongly correlated, suggesting a degree of acclimation. Defoliation treatments had great impacts on berry size, berries per cluster, and total soluble solids in both years. Fruit removal treatments only had effects on berry mass and berries per cluster in the first season, and only on berry soluble solids in the second. The predominant effect of defoliation (carbon starvation) cascaded onto reducing root starch content, root mass and delaying of veraison and leaf senescence, as well as harvest which was delayed up to 9 weeks with 33% of the leaves retained. In a third season, where grapevines grew without treatments, defoliation treatments had resultant carryover effects, including reduced leaf area, number of berries per cluster, clusters per vine, and yield, but not on leaf gas exchange dependent on previous seasons' severity of defoliation. Balancing source-to-sink ratio is crucial to obtain an adequate speed of ripening. However, this was the culmination of a more complex whole-plant regulation where the number of leaves (source strength) outweighed the effects of fruits (sink strength).

Dataset Information

Drugs Being Eliminated via the Same Pathway Will Not Always Require Similar Pediatric Dose Adjustments.

Publications

Drugs Being Eliminated via the Same Pathway Will Not Always Require Similar Pediatric Dose Adjustments.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets